{
  "nct_id": "NCT60080773",
  "indication": "Melanoma",
  "phase": "Phase 1",
  "sample_size": 59,
  "duration_weeks": 16,
  "dropout_rate": 0.09,
  "blinding": "double-blind",
  "control_arm": "active comparator",
  "primary_endpoints": [
    "Objective response rate"
  ],
  "secondary_endpoints": [
    "Overall survival",
    "Progression-free survival"
  ],
  "outcome_summary": "Statistically significant improvement on primary and key secondary endpoints",
  "success": 1,
  "start_date": "2021-12-21",
  "completion_date": "2022-04-12"
}